TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
Needham, MA (PRWEB) September 27, 2013 -- TrialNetworks, an innovative technology company which provides the global pharmaceutical industry’s only Clinical Trial Optimization System, will sponsor and actively participate in the following prominent and collaborative events next month:
• Clinical Operations Retreat for Executives (CORE) – Brewster, MA, October 2-4
• The Site Solutions Summit – Amelia Island, FL, October 11-13
• Clinical Trial Optimization – Bethesda, MD, October 21-22
At Clinical Trial Optimization, a top-10 pharmaceutical company will present findings on using TrialNetworks technology to improve patient enrollment and trial execution in a global study. The TrialNetworks system is used by study sponsors from small biotechs to large global pharmas to optimize operations from startup through closeout – including feasibility, site activation, patient recruitment and retention, site engagement, trial conduct, online training, document management and more – all integrated within one centralized cloud-based platform.
Eric Silberstein, TrialNetworks CEO, said, “Our team is comprised of expert technologists with a deep understanding and appreciation of clinical research, and former study practitioners who are passionate about using technology to improve trial operations. We place tremendous value on sponsoring industry conferences because they provide an ideal opportunity to build strong relationships with key opinion leaders and learn about the evolving challenges our customers face.”
About TrialNetworks
TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using modern and intuitive technology, the TrialNetworks platform increases the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist, Document Library, Visit Guide, Action Items and Directory, are available in a unified and secure cloud-based interface. Customers ranging from Top 10 pharmaceutical companies to biotechs have implemented the TrialNetworks platform for use in Phase I-IV studies by more than 20,000 site staff in 60 countries. To learn why sponsors rely on TrialNetworks to optimize clinical trial operations, request a personalized demo at http://www.trialnetworks.com.
Kristopher Sarajian, TrialNetworks, +1 6179524071 132, [email protected]
Share this article